Krystal Biotech Inc (KRYS) Company Profile & Statistics

Krystal Biotech Inc
KRYS
(Nasdaq - US)
Open
173.55
+2.81 (+1.65%)
in:usd•As of: Nov 18, 2024 12:45 UTC -5
Open
172.62
High
174.29
Low
168.64

About Krystal Biotech Inc

CEO

Krish S. Krishnan

Headquarters

2100 wharton street, suite 701

pittsburgh, pa 15203, united states

Auditor

KPMG LLP

Employees

229

Share Holders

Website

www.krystalbio.com

Industry

biotechnology

Sector

health technology

Company Overview

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Krystal Biotech Inc Statistics

Valuation Measures

Market Capitalization ²	4.99B
Enterprise Value	4.62B
Enterprise Value/EBITDA (ttm)	143.46
Price to Earnings Ratio (ttm)	81.31
Price to Book (mrq)	5.54
Price to Sales (ttm)	20.33
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	92.83%
Operating Margin (ttm)	25.77%
Profit Margin (ttm)	19.31%
Return on Equity (ttm)	7.54%
Return on Invested Capital (ttm)	6.16%
Return on Assets (ttm)	6.97%

Income Statement

Revenue (ttm)	241.52M
Revenue Per Share (ttm)	8.40
Gross Profit (ttm)	223.54M
EBITDA (ttm)³	32.19M
Net Income Avi to Common (ttm)	52.37M
Diluted EPS (ttm)	1.77

Share Statistics

Beta (5Y Monthly)	0.82
52-Week Change	65.63%
S&P500 52-Week Change	29.68%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	28.76M
Dividend Yield	0.00%
Float ⁴	24.71M
% Held by Insiders	14.10%
% Held by Institutions	86.29%

Balance Sheet

Total Cash (mrq)	588.32M
Total Cash Per Share (mrq)	20.46
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.97%
Quick Ratio (mrq)	7.76%
Book Value Per Share (mrq)	30.80

Cash Flow

Operating Cash Flow Per Share (ytd)	2.36
Free Cash Flow (ytd)	67.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Krystal Biotech Inc

Trade With A Regulated Broker